Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer

Objectives. To compare pathologic outcomes after treatment with gemcitabine and cisplatin (GC) versus methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) in the neoadjuvant setting. Methods. Data was retrospectively collected on 178 patients with T2-T4 bladder cancer who underwent radical cy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Franklin C., Harris, William, Cheng, Heather H., Shenoi, Jaideep, Zhao, Song, Wang, Junfeng, Champion, Thomas, Izard, Jason, Gore, John L., Porter, Michael, Yu, Evan Y., Wright, Jonathan L.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871504/
https://ncbi.nlm.nih.gov/pubmed/24382958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/317190
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados